White House Stands By Behind-The-Scenes Deal With Drugmakers Under Industry Pressure

White House Stands By Behind-The-Scenes Deal With Drugmakers Under Industry Pressure

Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion.

Popular in the Community

Close

What's Hot